Vitreous Penetration of Orally Administered Famciclovir

American Journal of Ophthalmology

Volumn 148, Issue 1, 2009, Pages

  Chong, Deborah Y ^a   Johnson, Mark W ^a   Huynh, Tony H ^a   Hall, Edward F ^a   Comer, Grant M ^a   Fish, Douglas N ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FAMCICLOVIR; PENCICLOVIR;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD SAMPLING; CILIARY DISK; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PENETRATION; DRUG VITREOUS LEVEL; FEMALE; HEADACHE; HERPES SIMPLEX VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION; KIRISAWA UVEITIS; LIVER FUNCTION; MALE; NAUSEA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; VARICELLA ZOSTER VIRUS; VITRECTOMY; VITREOUS BODY;

2-AMINOPURINE; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EYE INFECTIONS, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PRODRUGS; PROSPECTIVE STUDIES; RETINAL NECROSIS SYNDROME, ACUTE; VITRECTOMY; VITREOUS BODY;

EID: 67349100161     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.02.010     Document Type: Article

References (30)

1. Holland G.N. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol 117 (1994) 663-667
2. Fisher J.P., Lewis M.L., Blumenkranz M., et al. The acute retinal necrosis syndrome. Part 1: Clinical manifestations. Ophthalmology 89 (1982) 1309-1316
3. Blumenkranz M.S., Culbertson W.W., Clarkson J.G., and Dix R. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology 93 (1986) 296-300
4. Chang S., and Young L.H. Acute retinal necrosis: An overview. Int Ophthalmol Clin 47 (2007) 145-154
5. Duker J.S., and Blumenkranz M.S. Diagnosis and management of the acute retinal necrosis (ARN) syndrome. Surv Ophthalmol 35 (1991) 327-343
6. Muthiah M.N., Michaelides M., Child C.S., and Mitchell S.M. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the United Kingdom. Br J Ophthalmol 91 (2007) 1452-1455
7. Palay D.A., Sternberg Jr. P., Davis J., et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol 112 (1991) 250-255
8. Aizman A. Treatment of acute retinal necrosis syndrome. Drugs Today 42 (2006) 545-551
9. Figueroa M.S., Garabito I., Gutierrez C., and Fortun J. Famciclovir for the treatment of acute retinal necrosis (ARN) syndrome. Am J Ophthalmol 123 (1997) 255-257
10. Schulman J.A., Peyman G.A., Fiscella R.G., et al. Parenterally administered acyclovir for viral retinitis associated with AIDS. Arch Ophthalmol 102 (1984) 1750
11. Aslanides I.M., De Souza S., Wong D.T., et al. Oral valacyclovir in the treatment of acute retinal necrosis syndrome. Retina 22 (2002) 352-354
12. Emerson G.G., Smith J.R., Wilson J.D., et al. Primary treatment of acute retinal necrosis with oral antiviral therapy. Ophthalmology 113 (2006) 2259-2261
13. Savant V., Saeed T., Denniston A., and Murray P.I. Oral valganciclovir treatment of varicella zoster virus acute retinal necrosis. Eye 18 (2004) 544-545
14. Aizman A., Johnson M.W., and Elner S.G. Treatment of acute retinal necrosis syndrome with oral antiviral medications. Ophthalmology 114 (2007) 307-312
15. Famvir (famciclovir) Prescribing Information. http://www.fda.gov/medwatch/SAFETY/2006/Feb_PI/Famvir_PI.pdf Accessed: November 17, 2008.
16. Chakrabarty A., Tyring S.K., Beutner K., and Rauser M. Recent clinical experience with famciclovir-a "third generation" nucleoside prodrug. Antivir Chem Chemother 15 (2004) 251-253
17. Soul-Lawton J., Seaber E., On N., et al. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 39 (1995) 2759-2764
18. Fletcher C., and Bean B. Evaluation of oral acyclovir therapy. Drug Intell Clin Pharm 19 (1985) 518-524
19. Crumpacker C. The pharmacological profile of famciclovir. Semin Dermatol 15 (1996) 14-26
20. Valtrex (valacyclovir) Prescribing Information. http://www.fda.gov/medwatch/safety/2005/Nov_PI/Valtrex_PI.pdf Accessed: November 17, 2008.
21. Huynh T.H., Johnson M.W., Comer G.M., and Fish D.N. Vitreous penetration of orally administered valacyclovir. Am J Ophthalmol 145 (2008) 682-686
22. Balfour Jr. H.H. Chapter 32: Acyclovir. In: Peterson P.K., and Verhoeft J. (Eds). Antimicrobial Agents Annual 3 (1988), Elsevier, Amsterdam, The Netherlands 345-360
23. Pepose J.S., and Biron K. Antiviral sensitivities of the acute retinal necrosis syndrome virus. Curr Eye Res 6 (1987) 201-205
24. Höglund M., Ljungman P., and Weller S. Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients. J Antimicrob Chemother 47 (2001) 855-861
25. Oueghlani E., Baglivo E., Durakovic O., and Safran A.B. Varicella-zoster virus retinitis: successful evolution with a combination of antiviral therapies. Klin Monatsbl Augenheilkd 222 (2005) 264-266
26. Tran T.H., Rozenberg F., Fillet A.M., and Bodaghi B. Diagnostic and therapeutic management of a severe acyclovir-resistant acute retinal necrosis in a young child. Graefes Arch Clin Exp Ophthalmol 243 (2005) 266-268
27. Teich S.A., Cheung T.W., and Friedman A.H. Systemic antiviral drugs used in ophthalmology. Surv Ophthalmol 37 (1992) 19-53
28. Hasegawa T., Kurokawa M., Yukawa T.A., Horii M., and Shiraki K. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella zoster virus to PCV. Antiviral Res 27 (1995) 271-279
29. Safrin S., and Phan L. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus. Antimicrob Agents Chemother 37 (1993) 2241-2243
30. Talarico C.L., Phelps W.C., and Biron K.K. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella zoster virus isolated from patients with AIDS. J Virol 67 (1993) 1024-1033